
Ensign Peak Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $214M | Sell |
526,587
-246,822
| -32% | -$100M | 0.37% | 56 |
|
2025
Q1 | $385M | Sell |
773,409
-287,534
| -27% | -$143M | 0.74% | 22 |
|
2024
Q4 | $552M | Sell |
1,060,943
-22,086
| -2% | -$11.5M | 0.98% | 14 |
|
2024
Q3 | $670M | Sell |
1,083,029
-90,466
| -8% | -$56M | 1.18% | 12 |
|
2024
Q2 | $649M | Sell |
1,173,495
-46,164
| -4% | -$25.5M | 1.19% | 13 |
|
2024
Q1 | $709M | Buy |
1,219,659
+132,781
| +12% | +$77.2M | 1.29% | 11 |
|
2023
Q4 | $577M | Buy |
1,086,878
+233,126
| +27% | +$124M | 1.14% | 11 |
|
2023
Q3 | $432M | Buy |
853,752
+62,973
| +8% | +$31.9M | 0.92% | 17 |
|
2023
Q2 | $413M | Buy |
790,779
+23,195
| +3% | +$12.1M | 0.84% | 18 |
|
2023
Q1 | $442M | Buy |
767,584
+2,863
| +0.4% | +$1.65M | 0.96% | 17 |
|
2022
Q4 | $421M | Sell |
764,721
-14,563
| -2% | -$8.02M | 0.95% | 19 |
|
2022
Q3 | $395M | Buy |
779,284
+19,273
| +3% | +$9.78M | 0.98% | 15 |
|
2022
Q2 | $413M | Buy |
760,011
+6,694
| +0.9% | +$3.64M | 0.98% | 15 |
|
2022
Q1 | $445M | Sell |
753,317
-51,943
| -6% | -$30.7M | 0.9% | 21 |
|
2021
Q4 | $537M | Sell |
805,260
-16,682
| -2% | -$11.1M | 1.03% | 12 |
|
2021
Q3 | $470M | Sell |
821,942
-34,857
| -4% | -$19.9M | 0.98% | 12 |
|
2021
Q2 | $432M | Sell |
856,799
-19,822
| -2% | -$10M | 0.87% | 17 |
|
2021
Q1 | $400M | Sell |
876,621
-61,007
| -7% | -$27.8M | 0.86% | 17 |
|
2020
Q4 | $437M | Sell |
937,628
-46,102
| -5% | -$21.5M | 0.99% | 13 |
|
2020
Q3 | $434M | Sell |
983,730
-39,505
| -4% | -$17.4M | 1.1% | 12 |
|
2020
Q2 | $371M | Sell |
1,023,235
-34,022
| -3% | -$12.3M | 1.01% | 12 |
|
2020
Q1 | $300M | Sell |
1,057,257
-886
| -0.1% | -$251K | 1% | 15 |
|
2019
Q4 | $344M | Buy |
+1,058,143
| New | +$344M | 0.91% | 17 |
|